Navigation

Home Search
Browse
Structure
Tools
Important
Help About us Contact us

Papers published in PubMed in last 60 days

(Data retrieved on Fri Dec 23 20:32:03 IST 2011 )



  1. Cellular uptake and biophysical properties of galactose and/or tryptophan containing cell-penetrating peptides.
  2. Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy.
  3. Pharmacokinetically Stabilized Cystine Knot Peptides that Bind Alpha-v-Beta-6 Integrin with Single-Digit Nanomolar Affinities for Detection of Pancreatic Cancer.
  4. A gene delivery system for insect cells mediated by arginine-rich cell-penetrating peptides.
  5. Comparison of Cationic and Amphipathic Cell Penetrating Peptides for siRNA Delivery and Efficacy.
  6. Synergistic effects of conjugating cell penetrating peptides and thiomers on non-viral transfection efficiency.
  7. Novel Cell-Penetrating Peptides Based on alpha-Aminoxy Acids.
  8. The role of endocytosis on the uptake kinetics of luciferin-conjugated cell-penetrating peptides.
  9. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: Implications in cancer treatment.
  10. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: Characterisation of inverso mastoparan as a highly efficient cell penetrating peptide.
  11. The natural cell-penetrating peptide crotamine targets tumor tissue in vivo and triggers a lethal calcium-dependent pathway in cultured cells.
  12. Detection of a Prognostic Indicator in Early-Stage Cancer Using Functionalized Graphene-Based Peptide Sensors.
  13. MR Molecular Imaging of Prostate Cancer with a Peptide-Targeted Contrast Agent in a Mouse Orthotopic Prostate Cancer Model.
  14. Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides.
  15. An Artificial Copper Complex Incorporating a Cell-Penetrating Peptide Inhibits Nuclear Factor-kappaB (NF-kappaB) Activation.
  16. Sensitivity of Saccharomyces cerevisiae to the cell-penetrating antifungal peptide PAF26 correlates with endogenous nitric oxide (NO) production.
  17. Low Plasma Level of Atrial Natriuretic Peptide Predicts Development of Diabetes: The Prospective Malmo Diet and Cancer Study.
  18. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
  19. Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells.
  20. Synthesis of the Cancer Preventive Peptide Lunasin by Lactic Acid Bacteria During Sourdough Fermentation.
  21. Effective treatment of experimental ragweed-induced asthma with STAT-6-IP, a topically delivered cell-penetrating peptide.
  22. Targeting Interleukin-4 Receptor alpha with Hybrid Peptide for Effective Cancer Therapy.
  23. Anti-genotoxic potential of casein phosphopeptides (CPPs): a class of fermented milk peptides against low background radiation and prevention of cancer in radiation workers.
  24. Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose.
  25. Antimicrobial and cell-penetrating peptides induce lipid vesicle fusion by folding and aggregation.
  26. Screening of cell-penetrating peptides using mRNA display.
  27. Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer.
  28. Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination.
  29. In Vivo Near-Infrared Fluorescence Imaging of Integrin alpha2beta1 in Prostate Cancer with Cell-Penetrating-Peptide-Conjugated DGEA Probe.
  30. Peptides in cancer nanomedicine: Drug carriers, targeting ligands and protease substrates.
  31. Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment.
  32. Protein transduction into the mouse otocyst using arginine-rich cell-penetrating peptides.
  33. Immobilized thermolysin for highly efficient production of low-molecular-weight protamine-An attractive cell-penetrating peptide for macromolecular drug delivery applications.
  34. Cell-penetrating conjugates of coproporphyrins with oligoarginine peptides: rational design and application for sensing intracellular o(2).
  35. Synergistic effects of cell-penetrating peptide Tat and fusogenic peptide HA2-enhanced cellular internalization and gene transduction of organosilica nanoparticles.
  36. X-Ray Computed Tomography Imaging of Breast Cancer by using Targeted Peptide-Labeled Bismuth Sulfide Nanoparticles.
  37. Cell-penetrating peptides as antifungals towards Malassezia sympodialis.

Papers published in PubMed in last 60 days

(Data retrieved on Sat May 18 21:53:53 IST 2013 )



  1. Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake.
  2. Serum peptidome variations in a healthy population: reference to identify cancer-specific peptides.
  3. Cationic Cell-Penetrating Peptide Binds to Planar Lipid Bilayers Containing Negatively Charged Lipids but does not Induce Conductive Pores.
  4. Cell-Penetrating Peptide Enhanced Intracellular Raman Imaging and Photodynamic Therapy.
  5. A Mitochondria-Targeting Gold-Peptide Nanoassembly for Enhanced Cancer-Cell Killing.
  6. Combined effect of a peptide-morpholino oligonucleotide conjugate and a cell-penetrating peptide as an antibiotic.
  7. A Multicenter Randomized Phase IIb Efficacy Study of Vx-001, a Peptide-Based Cancer Vaccine as Maintenance Treatment in Advanced Non-Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics.
  8. Therapeutic potential of cell-penetrating peptides.
  9. Identification of HLA Class I-binding Peptides Derived from Unique Cancer-associated Proteins by Mass Spectrometric Analysis.
  10. Novel targeted nuclear imaging agent for gastric cancer diagnosis: glucose-regulated protein 78 binding peptide-guided (111)In-labeled polymeric micelles.
  11. Discovery of PTPRJ Agonist Peptides That Effectively Inhibit in Vitro Cancer Cell Proliferation and Tube Formation.
  12. Prophylactic effect of a peptide vaccine targeting TM4SF5 against colon cancer in a mouse model.
  13. Oral delivery of oil-based formulation for a novel synthetic cationic peptide of GnRH (gonadotropin-releasing hormone) antagonist for prostate cancer treatment.
  14. Modification of a Designed Amphipathic Cell-Penetrating Peptide and Its Effect on Solubility, Secondary Structure, and Uptake Efficiency.
  15. Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer.
  16. Translocation of Cell Penetrating Peptides on Chlamydomonas reinhardtii.
  17. Natriuretic peptides' metabolic targets for treatment of cancer.
  18. HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer.
  19. Glucagon-Like Peptide-1 Receptor Imaging with [Lys (40) (Ahx-HYNIC- (99 m) Tc/EDDA)NH 2 ]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report.
  20. Multi-peptide nLC-PC-IDMS-SRM-based Assay for the quantification of biomarkers in the chicken ovarian cancer model.
  21. Molecular Parameters of siRNA-Cell Penetrating Peptide Nanocomplexes for Efficient Cellular Delivery.
  22. [In situ rat intestine absorption of paclitaxel-loaded solid lipid nanoparticles modified with cell-penetrating peptides].
  23. Relapse or eradication of cancer is predicted by Peptide-major histocompatibility complex affinity.
  24. Targeting the EGFR/PCNA Signaling Suppresses Tumor Growth of Triple-Negative Breast Cancer Cells with Cell-Penetrating PCNA Peptides.
  25. Collagen-like Cell-Penetrating Peptides.
  26. Evaluation of cell-penetrating peptide/adenovirus particles for transduction of CAR-negative cells.
  27. A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.
  28. Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs.
  29. VaccImm: simulating peptide vaccination in cancer therapy.
  30. Intracellular translocation and differential accumulation of cell-penetrating peptides in bovine spermatozoa: evaluation of efficient delivery vectors that do not compromise human sperm motility.
  31. Glucagon-like peptide 2 in colon carcinogenesis: Possible target for anti-cancer therapy?
  32. Anticancer mechanisms of temporin-1CEa, an amphipathic alpha-helical antimicrobial peptide, in Bcap-37 human breast cancer cells.
  33. Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer.
  34. Rapid Cytotoxicity of Antimicrobial Peptide Tempoprin-1CEa in Breast Cancer Cells through Membrane Destruction and Intracellular Calcium Mechanism.
  35. [Cell-penetrating peptide].
  36. Haptoglobin proved a prognostic biomarker in peripheral blood of patients with personalized Peptide vaccinations for advanced castration-resistant prostate cancer.
  37. In Vivo Detection of Human TRPV6-Rich Tumors with Anti-Cancer Peptides Derived from Soricidin.
  38. Targeting Hepatic Cancer Cells with PEGylated Dendrimers Displaying N-Acetylgalactosamine and SP94 Peptide Ligands.
  39. Cancer immunotherapy: present status, future perspective, and a new paradigm of peptide immunotherapeutics.
  40. Intracellular delivery of liposomes using cell-penetrating peptides.
  41. Peptide hydrogelation and cell encapsulation for 3D culture of MCF-7 breast cancer cells.
  42. Effect of CD44 binding peptide conjugated to an engineered inert matrix on maintenance of breast cancer stem cells and tumorsphere formation.
  43. The potent antimicrobial properties of cell penetrating peptide-conjugated silver nanoparticles with excellent selectivity for Gram-positive bacteria over erythrocytes.
  44. Direct translocation of cell-penetrating peptides in liposomes: A combined mass spectrometry quantification and fluorescence detection study.
  45. In silico approaches for designing highly effective cell penetrating peptides.
  46. Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation.
  47. Peptide modified polymeric micelles specific for breast cancer cells.
  48. Early stages of interactions of cell-penetrating peptide penetratin with a DPPC bilayer.
  49. Mechanistic studies of intracellular delivery of proteins by cell-penetrating peptides in cyanobacteria.